MAPK3 and colorectal cancer: One of the molecular mechanisms underlying anti-cancer effects of FTY720 in colorectal cancer cells included restoration of the activity of tumor suppressor protein phosphatase 2A (PP2A) and the resulting suppression of the activity of its targets AKT and ERK1/2 [59].